Chicago’s endowment participated in the series A, following a $1.1m seed round last year that included prize money from the Chicago-run New Venture Challenge.

HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.

Building on work at MIT’s Koch Institute of Integrative Cancer Research, Elicio hopes to begin patient studies in 2020 for pancreatic, colorectal, head and neck cancers.

Founded by a former research engineer from regional TTO Satt AxLR, genetic analysis platform company SeqOne has become one of the first businesses to be backed by the PSL Innovation Fund.

IP Group, CIC and Johnson & Johnson have returned for a $52.2m series B round in Inivata, a spinout of Cancer Research UK and University of Cambridge.

Liverpool's health sciences academic assessment software spinout has been bought by exam platform ExamSoft, which will augment and integrate its services.

The university has reportedly backed an oversubscribed $1.5bn buyout vehicle launched by Arcline aiming to take over eight-to-10 mid-market companies.

Robert Bahns has stepped down as technology partner at IP Group to become chief financial officer at one of the firm’s portfolio businesses, WaveOptics.

Sofinnova Partners and New Enterprise Associates have co-led an oversubscribed series A round for Polyneuron Pharmaceuticals, spun out of University of Basel.

Goethe University Frankfurt has spun out Vivlion to commercialise a library of the human genome that could drive the development of more Crispr therapies.